CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 114 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $25,000 | -51.9% | 1,500 | -25.0% | 0.01% | -55.2% |
Q4 2017 | $52,000 | +246.7% | 2,000 | +100.0% | 0.03% | +222.2% |
Q3 2017 | $15,000 | +7.1% | 1,000 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $14,000 | -46.2% | 1,000 | -33.3% | 0.01% | -43.8% |
Q1 2017 | $26,000 | +23.8% | 1,500 | -25.0% | 0.02% | +23.1% |
Q4 2016 | $21,000 | +5.0% | 2,000 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $20,000 | +17.6% | 2,000 | +33.3% | 0.01% | +8.3% |
Q2 2016 | $17,000 | – | 1,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |